healthcare

healthcare Articles

Walgreens reported better than expected fiscal fourth-quarter financial results before the markets opened on Monday.
Melinta shares dropped on Friday even though the firm announced that the FDA has approved Baxdela (delafloxacin) for the treatment of adult patients with community-acquired bacterial pneumonia.
The October 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
The October 15 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
The October 15 short interest data have been compared with the previous figures, and short interest in these selected marijuana stocks were mixed.
A new Gallup poll shows that two-thirds of Americans believe marijuana use should be legal, up sharply from 50 years ago.
Eli Lilly shares retreated after it released mixed third-quarter financial results before the markets opened on Wednesday.
Eton Pharma shares jumped on Tuesday after the firm announced that the FDA has approved Biorphen for treatment of hypotension.
Biogen released its third-quarter financial results and Alzheimer’s trial news before the markets opened on Tuesday.
Seattle Genetics shares jumped on Monday after the firm announced positive results from its midstage breast cancer trial.
Over the past four years, the economic cost of the opioid epidemic has cost the United States some $631 billion. And with more deaths possible, the costs could soar.
Axsome Therapeutics shares made a handy gain on Wednesday after the firm announced that it has completed patient enrollment in its Gemini study, a Phase 3 trial of AXS-05 in patients with major...
Achillion Pharmaceuticals shares skyrocketed on Wednesday morning on news that the firm would be acquired by Alexion Pharmaceuticals.
Reata Pharma shares jumped on Tuesday after the firm announced positive results from its midstage neuromuscular disorder drug trial.
Johnson & Johnson reported better than expected quarterly results before the markets opened on Tuesday.